Peptides and protein drug delivery system

The evolution of protein and peptide therapeutic market has developed significantly in the past decades with the advancement of peptide and protein drug delivery system. Although oral delivery is preferred, most are currently delivered intravenously or subcutaneously thanks to degradation and limited absorption within the alimentary canal. Due to rapid progress in biotechnology, as well as gene technology, the industry can produce many potential therapeutic peptides and proteins in commercial quantities. Endogenous proteins and peptides play a crucial role within the regulation and integration of life processes and act with high specificity and potency. Peptides and proteins have great potential as therapeutics. Currently, the marketplace for peptide and protein drugs is estimated to be greater than US$40 billion/year, or 10% of the pharmaceutical market. This market is growing much faster than that of small molecules and will make up an even larger proportion of the market in the future.

  • Track 11-1Peptide Vector for Biologics Brain Delivery
  • Track 11-2Protein & peptide therapeutics
  • Track 11-3Cell-penetrating and cell-targeting
  • Track 11-4Oxidation and deduction

 

 

Related Conference of Pharmaceutical Sciences